ATE225660T1 - Verfahren zur verwendung von cyclooxygenase-2 hemmern zur behandlung und vorbeugung der demenz - Google Patents
Verfahren zur verwendung von cyclooxygenase-2 hemmern zur behandlung und vorbeugung der demenzInfo
- Publication number
- ATE225660T1 ATE225660T1 AT98912108T AT98912108T ATE225660T1 AT E225660 T1 ATE225660 T1 AT E225660T1 AT 98912108 T AT98912108 T AT 98912108T AT 98912108 T AT98912108 T AT 98912108T AT E225660 T1 ATE225660 T1 AT E225660T1
- Authority
- AT
- Austria
- Prior art keywords
- cyclooxygenase
- inhibitors
- treat
- prevent dementia
- dementia
- Prior art date
Links
- 206010012289 Dementia Diseases 0.000 title abstract 3
- 239000003255 cyclooxygenase 2 inhibitor Substances 0.000 title abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
- A61K31/635—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US4391697P | 1997-04-03 | 1997-04-03 | |
| PCT/US1998/006143 WO1998043648A1 (en) | 1997-04-03 | 1998-03-30 | Method of using cyclooxygenase-2 inhibitors in the treatment and prevention of dementia |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE225660T1 true ATE225660T1 (de) | 2002-10-15 |
Family
ID=21929578
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT98912108T ATE225660T1 (de) | 1997-04-03 | 1998-03-30 | Verfahren zur verwendung von cyclooxygenase-2 hemmern zur behandlung und vorbeugung der demenz |
Country Status (12)
| Country | Link |
|---|---|
| EP (1) | EP0971714B1 (de) |
| JP (1) | JP2002514208A (de) |
| AT (1) | ATE225660T1 (de) |
| AU (1) | AU725697B2 (de) |
| BR (1) | BR9807920A (de) |
| CA (1) | CA2285434A1 (de) |
| DE (1) | DE69808607T2 (de) |
| DK (1) | DK0971714T3 (de) |
| ES (1) | ES2185154T3 (de) |
| PT (1) | PT971714E (de) |
| WO (1) | WO1998043648A1 (de) |
| ZA (1) | ZA982808B (de) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6727238B2 (en) | 1998-06-11 | 2004-04-27 | Pfizer Inc. | Sulfonylbenzene compounds as anti-inflammatory/analgesic agents |
| US6294558B1 (en) | 1999-05-31 | 2001-09-25 | Pfizer Inc. | Sulfonylbenzene compounds as anti-inflammatory/analgesic agents |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9420616D0 (en) * | 1994-10-12 | 1994-11-30 | Merck Sharp & Dohme | Method, compositions and use |
| ES2141916T3 (es) * | 1993-11-30 | 2000-04-01 | Searle & Co | Pirazolil-bencenosulfonamidas sustituidas para el tratamiento de la inflamacion. |
| US5486534A (en) * | 1994-07-21 | 1996-01-23 | G. D. Searle & Co. | 3,4-substituted pyrazoles for the treatment of inflammation |
| US5696143A (en) * | 1994-09-20 | 1997-12-09 | Talley; John J. | Benz G! indazolyl derivatives for the treatment of inflammation |
| US5547975A (en) * | 1994-09-20 | 1996-08-20 | Talley; John J. | Benzopyranopyrazolyl derivatives for the treatment of inflammation |
| US5643933A (en) * | 1995-06-02 | 1997-07-01 | G. D. Searle & Co. | Substituted sulfonylphenylheterocycles as cyclooxygenase-2 and 5-lipoxygenase inhibitors |
| AU5886296A (en) * | 1995-06-02 | 1996-12-18 | G.D. Searle & Co. | Heterocyclo substituted hydroxamic acid derivatives as cyclo oxygenase-2 and 5-lipoxygenase inhibitors |
| US6136839A (en) * | 1995-06-12 | 2000-10-24 | G. D. Searle & Co. | Treatment of inflammation and inflammation-related disorders with a combination of a cyclooxygenase-2 inhibitor and a 5-lipoxygenase inhibitor |
| US5700816A (en) * | 1995-06-12 | 1997-12-23 | Isakson; Peter C. | Treatment of inflammation and inflammation-related disorders with a combination of a cyclooxygenase-2 inhibitor and a leukotriene A4 hydrolase inhibitor |
| JPH11507669A (ja) * | 1995-06-12 | 1999-07-06 | ジー．ディー．サール アンド カンパニー | シクロオキシゲナーゼ−２インヒビターとロイコトリエンｂ▲下４▼受容体アンタゴニストの組合せによる炎症と炎症関連疾患の治療 |
| GEP20032998B (en) * | 1996-04-12 | 2003-06-25 | Searle & Co | Substituted Benzenesulfonamide Derivatives as Prodrugs of Cox-2 Inhibitors |
-
1998
- 1998-03-30 PT PT98912108T patent/PT971714E/pt unknown
- 1998-03-30 DE DE69808607T patent/DE69808607T2/de not_active Expired - Fee Related
- 1998-03-30 CA CA002285434A patent/CA2285434A1/en not_active Abandoned
- 1998-03-30 EP EP98912108A patent/EP0971714B1/de not_active Expired - Lifetime
- 1998-03-30 AT AT98912108T patent/ATE225660T1/de not_active IP Right Cessation
- 1998-03-30 DK DK98912108T patent/DK0971714T3/da active
- 1998-03-30 AU AU65904/98A patent/AU725697B2/en not_active Ceased
- 1998-03-30 ES ES98912108T patent/ES2185154T3/es not_active Expired - Lifetime
- 1998-03-30 WO PCT/US1998/006143 patent/WO1998043648A1/en not_active Ceased
- 1998-03-30 JP JP54186898A patent/JP2002514208A/ja not_active Ceased
- 1998-03-30 BR BR9807920-4A patent/BR9807920A/pt not_active IP Right Cessation
- 1998-04-02 ZA ZA982808A patent/ZA982808B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| BR9807920A (pt) | 2000-02-22 |
| DE69808607D1 (de) | 2002-11-14 |
| CA2285434A1 (en) | 1998-10-08 |
| WO1998043648A1 (en) | 1998-10-08 |
| AU725697B2 (en) | 2000-10-19 |
| JP2002514208A (ja) | 2002-05-14 |
| ZA982808B (en) | 1999-04-06 |
| EP0971714A1 (de) | 2000-01-19 |
| ES2185154T3 (es) | 2003-04-16 |
| AU6590498A (en) | 1998-10-22 |
| EP0971714B1 (de) | 2002-10-09 |
| DK0971714T3 (da) | 2002-11-04 |
| PT971714E (pt) | 2002-12-31 |
| DE69808607T2 (de) | 2003-06-26 |
| HK1024872A1 (en) | 2000-10-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69815090D1 (de) | Verwendung von cholinesterasehemmer zur behandlung von konzentrationsstörungen | |
| ATE271385T1 (de) | Verwendung von cyclooxygenase-2 inhibitoren zur behandlung und verbeugung von neoplasia | |
| ATE242632T1 (de) | Verwendung von betulinsäure-derivaten zur behandlung und vorbeugung von melanomen | |
| ATE308880T1 (de) | Verfahren zur erhöhung der biologischen effektivität von zusammensetzungen zur pflanzenbehandlung | |
| DE69728594D1 (de) | Chromfreie Zusammensetzung zur Behandlung von Metalloberflächen | |
| ATE217865T1 (de) | Verbindungen zur hemmung von phosphodiesrerase iv | |
| ATE250932T1 (de) | Verfahren zur behandlung von chronischem schmerz durch verabreichung von einem mek hemmer | |
| ATE128143T1 (de) | 17-beta-substituierte-4-aza-5-alpha-androstan-3 one-derivate und verfahren zu ihrer herstellung. | |
| DE69603089D1 (de) | Zusammensetzung zur behandlung von mauerwerk | |
| ATE301995T1 (de) | Verwendung von derivaten der valproinsäureamide und 2-valproinsäureamid zur behandlung und prävention von schmerzen und/oder kopfschmerzen | |
| ATE259640T1 (de) | Verwendung von matrix-metalloproteinase inhibitoren zur förderung der wundheilung | |
| SE9602263D0 (sv) | New amino acid derivatives | |
| DE69433793D1 (de) | Phosphorderivate zur behandlung von aids | |
| DE69941821D1 (de) | Fluorenthaltende zusammensetzung zur behandlung von oberflächen | |
| ATE232191T1 (de) | Verfahren und zusammensetzung zur inhibierung der polymerisierung von ethylenisch ungesättigten kohlenwasserstoffen | |
| DE69937624D1 (de) | Verfahren zur Behandlung von Metalloberflächen | |
| DE59209268D1 (de) | Verfahren zur thermochemisch-thermischen behandlung von einsatzstählen | |
| DE59109225D1 (de) | Verwendung von pyridylmethylsulfinyl-1h-benzimidazol derivaten zur behandlung durch helicobacter verursachter erkrankungen | |
| DE69228814D1 (de) | Verfahren zur vorbeugung und behandlung von durch chemotherapie ausgelöster alopezie | |
| DE59705697D1 (de) | Verwendung von 1-hydroxy-2-pyridonen zur behandlung der seborrhoischen dermatitis | |
| DE69330465D1 (de) | Verfahren zur behandlung von chronischer prostatitis mit 17-beta-n-tertbutylcarbamoyl-4-aza-5 alpha-androst-1-en-3-one | |
| ATE225660T1 (de) | Verfahren zur verwendung von cyclooxygenase-2 hemmern zur behandlung und vorbeugung der demenz | |
| EP1102599A4 (de) | Protease hemmstoffe zur verwendung in der behandlung von psoriasis | |
| DE602004022423D1 (de) | Hemmung der s6-kinase-aktivität zur behandlung von insulinresistenz | |
| DE50003481D1 (de) | Verwendung von schmutzablösenden formulierungen zur behandlung von oberflächen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 0971714 Country of ref document: EP |
|
| REN | Ceased due to non-payment of the annual fee |